This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

MRSA Skin and Soft Tissue Infections: Applying IDSA Treatment Guidelines in Practice--Case 1

MRSA Skin and Soft Tissue Infections: Applying IDSA Treatment Guidelines in Practice--Case 1

Format

Patient Case Study

Time to Complete

30 minutes

Released

December 23, 2011

Expires

December 31, 2012

Program Description

Community-associated MRSA infections have become increasingly prevalent. People who live or work closely together without adhering fully to principles of good hygiene can inadvertently facilitate transmission. Here, a teenaged patient’s lesion reveals MRSA infection among his teammates.

Additional Resource:


Click here to view the Infectious Diseases Society of America's clinical practice guidelines for the treatment of MRSA infections.

Educational Objectives

At the conclusion of this educational activity, participants should be better able to:
  • Incorporate IDSA guidelines for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in practice

  • Treat MRSA skin and skin structure infections with attention to rational antibiotic use

  • Counsel patients on measures that reduce risk of recurrent MRSA infection

Disclosure

The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine of Yeshiva University requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical or equipment company.

Thomas M. File, Jr., MD, MSc, MACP, FIDSA, FCCP, has served as a consultant for Astellas, Bayer HealthCare Pharmaceuticals, Cempra, Daiichi-Sankyo, GSK, Merck, Nabriva Therapeutics, Pfizer, and Tetraphase Pharmaceuticals. He has also received grant/research support from Forest Laboratories, The Medicines Company, and Pfizer.

Ira Leviton, MD, has served as a speaker for Forest, Pfizer, and Cubist Pharmaceuticals. He also serves as a consultant for Pfizer.

Catherine Liu, MD, has served as a consultant for Cerexa, Inc.

David Talan, MD, has served as a consultant for Forest Laboratories, Merck, and Optimer Pharmaceuticals. He has also received grant/research support from Aggenix, Cepheid, Durata Therapeutics, Furiex Pharmaceuticals, Innovative Biosensors, Inc., Merck, Pfizer, and Pinnacle Pharmaceuticals.

Publishing Staff Disclosures
Ana Maria Albino and Jill Rovitzky Black of Haymarket Medical Education have nothing to disclose with regard to commercial support. Mary Desmond Pinkowish of Haymarket Medical Education is a stockholder in Abbott and Merck.

Accredited Provider Staff
The staff of the Center for Continuing Medical Education of Albert Einstein College of Medicine of Yeshiva University has nothing to disclose with regard to commercial support.

Disclosure of Unlabeled Use
This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Astellas Pharma US, Inc., Albert Einstein College of Medicine of Yeshiva University, and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Astellas Pharma US, Inc., Albert Einstein College of Medicine of Yeshiva University, and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings

Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Commercial Support Statement
This activity is supported through an independent educational grant from Astellas.





This activity is sponsored by Albert Einstein College of Medicine of Yeshiva University





This program is produced by Haymarket Medical Education.

Faculty

Faculty Chair
Thomas M. File, Jr., MD, MSc, MACP, FIDSA, FCCP

Chief, Infectious Disease Division
Summa Health System, Akron, OH
Professor of Internal Medicine, Master Teacher, and Chair, Infectious Disease Section
Northeast Ohio Medical University
Rootstown, Ohio

Faculty
David A. Talan, MD, FACEP, FAAEM, FIDSA (Author, Case 1)

Professor of Medicine in Residence, UCLA School of Medicine
Chairman, Department of Emergency Medicine
Faculty, Division of Infectious Diseases
Olive View-UCLA Medical Center
Los Angeles, CA

Catherine Liu, MD
Assistant Clinical Professor of Medicine
Division of Infectious Disease
University of California, San Francisco
San Francisco, CA

Course Director
Ira Leviton, MD

Associate Professor of Clinical Medicine,
Department of Medicine (Infectious Diseases)
Montefiore Medical Center
Bronx, NY

Intended Audience

Primary care, internal medicine, and family physicians, nurse practitioners, and physician assistants

Credit

0.50

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

Albert Einstein College of Medicine of Yeshiva University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement

Albert Einstein College of Medicine of Yeshiva University designates this enduring material for a maximum of 0.50 AMA PRA Category 1 CME Credits™. Physicians should only claim credit commensurate with the extent of their participation in this activity. This CME activity was planned and produced in accordance with the ACCME Essentials.

Instructions

To obtain credit, a score of 70% or better is required. This CME activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.

Privacy Policy
To view the myCME privacy policy, please click here.

To view the privacy policy for Albert Einstein College of Medicine of Yeshiva University and Montefiore, please click here.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue